NanJing Pharmaceutical Company Limited (SHA:600713)
China · Delayed Price · Currency is CNY 5.29
+0.07 (1.34%)
Jul 16, 2025, 2:45 PM CST
SHA:600713 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 570.63 | 577.83 | 595.67 | 505.18 | 376.41 | Upgrade |
Depreciation & Amortization | 251.42 | 270.4 | 260.47 | 241.48 | 135.81 | Upgrade |
Other Amortization | 34.05 | 18.34 | 16.1 | 17.44 | 22.82 | Upgrade |
Loss (Gain) From Sale of Assets | -3.85 | -1.75 | -23.79 | -60.54 | -66.12 | Upgrade |
Loss (Gain) From Sale of Investments | -4.02 | -8.58 | -2.88 | -7.57 | -0.42 | Upgrade |
Stock-Based Compensation | 7.93 | 17.59 | 16.56 | - | - | Upgrade |
Provision & Write-off of Bad Debts | 26.84 | -16.06 | 75.09 | 11.48 | 44.84 | Upgrade |
Other Operating Activities | 532.13 | 518.03 | 485.02 | 490.68 | 420.08 | Upgrade |
Change in Accounts Receivable | 454.05 | 3,807 | -4,990 | -1,360 | -1,819 | Upgrade |
Change in Inventory | -502.37 | -13.45 | -1,271 | -460.58 | -352.76 | Upgrade |
Change in Accounts Payable | 790.19 | -3,255 | 4,186 | 1,321 | 92.97 | Upgrade |
Change in Other Net Operating Assets | - | - | 0.98 | - | - | Upgrade |
Operating Cash Flow | 2,136 | 1,906 | -682.31 | 695.33 | -1,152 | Upgrade |
Operating Cash Flow Growth | 12.03% | - | - | - | - | Upgrade |
Capital Expenditures | -544.76 | -158.22 | -155.28 | -306.54 | -246.97 | Upgrade |
Sale of Property, Plant & Equipment | 7.09 | 6.6 | 93.31 | 37.89 | 38.96 | Upgrade |
Cash Acquisitions | - | -0 | - | -2 | -28.55 | Upgrade |
Divestitures | - | - | - | 0.2 | - | Upgrade |
Investment in Securities | -27.6 | -23.95 | 0.17 | 42.73 | - | Upgrade |
Other Investing Activities | 3.34 | 2.4 | 2.53 | 3.2 | 20.56 | Upgrade |
Investing Cash Flow | -561.93 | -173.18 | -59.26 | -224.52 | -216.01 | Upgrade |
Long-Term Debt Issued | 21,102 | 27,957 | 22,833 | 29,058 | 23,627 | Upgrade |
Total Debt Issued | 21,102 | 27,957 | 22,833 | 29,058 | 23,627 | Upgrade |
Long-Term Debt Repaid | -21,396 | -28,535 | -22,757 | -28,065 | -22,512 | Upgrade |
Total Debt Repaid | -21,396 | -28,535 | -22,757 | -28,065 | -22,512 | Upgrade |
Net Debt Issued (Repaid) | -293.92 | -578.53 | 75.14 | 992.89 | 1,115 | Upgrade |
Issuance of Common Stock | - | - | 1,030 | - | - | Upgrade |
Repurchase of Common Stock | -2.12 | -0.17 | - | - | - | Upgrade |
Common Dividends Paid | -504.83 | -587.94 | -482.89 | -934.87 | -352.76 | Upgrade |
Other Financing Activities | -38.91 | 9.87 | -155.37 | -27.17 | -12.95 | Upgrade |
Financing Cash Flow | -839.77 | -1,157 | 466.62 | 30.85 | 749.34 | Upgrade |
Net Cash Flow | 734.07 | 576.46 | -274.95 | 501.66 | -619.13 | Upgrade |
Free Cash Flow | 1,591 | 1,748 | -837.59 | 388.79 | -1,399 | Upgrade |
Free Cash Flow Growth | -8.99% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 2.96% | 3.26% | -1.67% | 0.86% | -3.52% | Upgrade |
Free Cash Flow Per Share | 1.22 | 1.35 | -0.67 | 0.37 | -1.34 | Upgrade |
Cash Income Tax Paid | 1,007 | 961.27 | 1,031 | 742.15 | 554.71 | Upgrade |
Levered Free Cash Flow | 1,456 | 3,354 | -2,793 | -338.73 | -1,222 | Upgrade |
Unlevered Free Cash Flow | 1,765 | 3,681 | -2,585 | -64.35 | -994.77 | Upgrade |
Change in Net Working Capital | -1,056 | -2,595 | 3,591 | 829.67 | 1,549 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.